SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-018920
Filing Date
2022-08-04
Accepted
2022-08-04 16:46:27
Documents
81
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbyi20220630_10q.htm   iXBRL 10-Q 1430723
2 EXHIBIT 31.1 ex_380812.htm EX-31.1 8208
3 EXHIBIT 31.2 ex_380813.htm EX-31.2 8207
4 EXHIBIT 32.1 ex_380814.htm EX-32.1 5088
5 EXHIBIT 32.2 ex_380815.htm EX-32.2 5106
  Complete submission text file 0001437749-22-018920.txt   7484240

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20220630.xsd EX-101.SCH 70538
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20220630_cal.xml EX-101.CAL 62562
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20220630_def.xml EX-101.DEF 454533
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20220630_lab.xml EX-101.LAB 422992
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20220630_pre.xml EX-101.PRE 490309
75 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20220630_10q_htm.xml XML 1235786
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 221137392
SIC: 2834 Pharmaceutical Preparations